We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NWLI
1876
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $461K | ﹤0.01% |
2,700
-500
| -16% | -$97.3K |
|
1877
Home Bancorp
HBCP
$558M
| $460K | ﹤0.01% |
11,800
-4,500
| -28% | -$173K |
|
1878
Kinsale Capital Group
KNSL
$8.58B
| $460K | ﹤0.01% |
1,800
+100
| +6% | +$24.9K |
|
|
PTVE
1879
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $460K | ﹤0.01% |
+52,700
| New | +$547K |
|
1880
Transmedics
TMDX
$2.7B
| $459K | ﹤0.01% |
+11,000
| New | +$478K |
|
1881
Hancock Whitney
HWC
$6.19B
| $458K | ﹤0.01% |
10,000
+5,300
| +113% | +$255K |
|
1882
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $451K | ﹤0.01% |
5,559
+900
| +19% | +$71.9K |
|
|
CMBM
1883
DELISTED
Cambium Networks
CMBM
| $450K | ﹤0.01% |
26,600
-11,600
| -30% | -$208K |
|
1884
Knowles
KN
$2.96B
| $449K | ﹤0.01% |
36,900
-19,900
| -35% | -$319K |
|
|
ICD
1885
DELISTED
Independence Contract Drilling, Inc.
ICD
| $447K | ﹤0.01% |
149,100
-73,300
| -33% | -$235K |
|
1886
Southside Bancshares
SBSI
$963M
| $446K | ﹤0.01% |
12,600
+4,000
| +47% | +$153K |
|
1887
Cigna
CI
$78.4B
| $444K | ﹤0.01% |
1,600
-19,500
| -92% | -$5.49M |
|
1888
Everspin Technologies
MRAM
$303M
| $443K | ﹤0.01% |
76,500
-30,600
| -29% | -$195K |
|
|
BRDG
1889
DELISTED
Bridge Investment Group
BRDG
| $442K | ﹤0.01% |
30,500
+5,300
| +21% | +$85.6K |
|
1890
Puma Biotechnology
PBYI
$398M
| $442K | ﹤0.01% |
186,600
+45,600
| +32% | +$133K |
|
|
USX
1891
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $442K | ﹤0.01% |
179,600
-49,600
| -22% | -$141K |
|
1892
Apogee Enterprises
APOG
$833M
| $440K | ﹤0.01% |
11,500
-9,300
| -45% | -$379K |
|
1893
eGain
EGAN
$186M
| $440K | ﹤0.01% |
59,900
-28,500
| -32% | -$256K |
|
1894
Liquidity Services
LQDT
$1.2B
| $439K | ﹤0.01% |
27,000
+100
| +0.4% | +$1.76K |
|
1895
Logitech
LOGI
$14.8B
| $437K | ﹤0.01% |
9,500
+160
| +2% | +$8.41K |
|
1896
Atkore
ATKR
$2.41B
| $436K | ﹤0.01% |
5,600
-17,700
| -76% | -$1.53M |
|
1897
Relay Therapeutics
RLAY
$4B
| $436K | ﹤0.01% |
+19,500
| New | +$428K |
|
1898
AMES National
ATLO
$271M
| $435K | ﹤0.01% |
19,600
-10,700
| -35% | -$237K |
|
|
JBGS
1899
JBG SMITH
JBGS
$846M
| $435K | ﹤0.01% |
+23,400
| New | +$536K |
|
|
SEMR
1900
DELISTED
Semrush
SEMR
| $435K | ﹤0.01% |
38,800
-3,500
| -8% | -$43.1K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.